Jason Pontin is a well-known venture capitalist, angel investor, and science and technology writer with an impressive background in the industry. With a BA, MA (Oxon) from the University of Oxford and Harrow School, Pontin has worked in various leadership positions throughout his career. For two decades, he served as the editor in chief and publisher of several magazines, specializing in science and technology. And now, he sits on the boards of a variety of life sciences and hard tech startups while investing and providing strategic advisory to several others.

Pontin's notable affiliations and involvements include serving as Board Chair, Cofounder, and Investor at Totus Medicines, a Scientific Advisory Board Member at Adlai Nortye Biopharma Co., Ltd., and a Board Observer and Investor at Menten AI. He has also previously contributed as a writer at WIRED and served as a Senior Advisor at Flagship Pioneering, a Strategic Advisor at Valo, and a Senior Partner and Chairman at MIT Enterprise Forum.

Pontin highly values education and has spent ample time advancing the conversation around transformative technologies through his journalism work and associations with world-renowned institutions. He served as the CEO, Editor in Chief, and Publisher at MIT Technology Review and the Editor in Chief at Acumen Journal of Life Sciences. He was an Associate at the Kennedy School of Government at Harvard University and spent time as a senior editor at InfoWorld.

In summary, Jason Pontin is an accomplished and highly respected figure in the world of technology and life sciences, who has contributed to major publications, led industry-leading organizations, and provided guidance to a vast range of startups.